Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Triton’s portfolio company Sunweb in connection with the acquisition of Airtours
Mandate

Vinge advises Triton’s portfolio company Sunweb in connection with the acquisition of Airtours

November 02, 2022 M&A

Vinge advises Triton’s portfolio company Sunweb Group, a leading Dutch travel company, in connection with the acquisition of Airtours – Sweden’s fourth largest tour operator.

Through the acquisition, Sunweb strengthens its existing operations in Sweden, and becomes one of the leading actors in the Nordics.

 

Vinge’s team consisted of, among others, Christina Kokko, Johanna Wiberg, Ulrich Ziche, Nando Basic and August Ahlin (M&A), Nour Makie (Banking and Finance), Michael Montner (IP), Lisa Hörnqvist and Sam Fakhraie Ardekani (Commercial agreements), Emil Lindwall (Employment) and Jasmina Skandrani (Project assistant).

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026